On March 25, 2025, Ward Morrison, President and CEO of Motto Mortgage and wemlo, subsidiaries of RE/MAX Holdings, Inc. (the “Company”), informed the Company of his intention to retire, effective June 15, 2025.
Adam Sartin, Vice President, Franchise Growth and Development, will lead the Motto Mortgage and wemlo brands while the Company continues its search for the next leader of Motto Mortgage and wemlo.
Departed
Dorothy D. Hayes
Director
INTEVAC INC
Effective
2025-03-31
Filed
March 31, 2025, 7:59 PM ET
each of Kevin Barber, David S. Dury, Dorothy D. Hayes, Nigel Hunton, Michele F. Klein, Eiji Miyanaga, and Ryan Vardeman resigned from his or her respective positions as a member of the Company’s board of directors and all committees thereof, effective as of the Effective Time
Departed
David S. Dury
Director
INTEVAC INC
Effective
2025-03-31
Filed
March 31, 2025, 7:59 PM ET
each of Kevin Barber, David S. Dury, Dorothy D. Hayes, Nigel Hunton, Michele F. Klein, Eiji Miyanaga, and Ryan Vardeman resigned from his or her respective positions as a member of the Company’s board of directors and all committees thereof, effective as of the Effective Time
Departed
Eiji Miyanaga
Director
INTEVAC INC
Effective
2025-03-31
Filed
March 31, 2025, 7:59 PM ET
each of Kevin Barber, David S. Dury, Dorothy D. Hayes, Nigel Hunton, Michele F. Klein, Eiji Miyanaga, and Ryan Vardeman resigned from his or her respective positions as a member of the Company’s board of directors and all committees thereof, effective as of the Effective Time
Departed
Ryan Vardeman
Director
INTEVAC INC
Effective
2025-03-31
Filed
March 31, 2025, 7:59 PM ET
each of Kevin Barber, David S. Dury, Dorothy D. Hayes, Nigel Hunton, Michele F. Klein, Eiji Miyanaga, and Ryan Vardeman resigned from his or her respective positions as a member of the Company’s board of directors and all committees thereof, effective as of the Effective Time
Appointed
James C. Lee
Director
INTEVAC INC
Effective
2025-03-31
Filed
March 31, 2025, 7:59 PM ET
James C. Lee, the sole director of the Purchaser immediately prior to the Effective Time, became the sole director of the Company
Departed
Kevin Barber
Director
INTEVAC INC
Effective
2025-03-31
Filed
March 31, 2025, 7:59 PM ET
each of Kevin Barber, David S. Dury, Dorothy D. Hayes, Nigel Hunton, Michele F. Klein, Eiji Miyanaga, and Ryan Vardeman resigned from his or her respective positions as a member of the Company’s board of directors and all committees thereof, effective as of the Effective Time
Appointed
Johnny Choi
Secretary
INTEVAC INC
Effective
2025-03-31
Filed
March 31, 2025, 7:59 PM ET
Johnny Choi, Secretary
Appointed
James C. Lee
President
INTEVAC INC
Effective
2025-03-31
Filed
March 31, 2025, 7:59 PM ET
Following the Effective Time, the officers of the Company are as follows: James C. Lee, President
Departed
Michele F. Klein
Director
INTEVAC INC
Effective
2025-03-31
Filed
March 31, 2025, 7:59 PM ET
each of Kevin Barber, David S. Dury, Dorothy D. Hayes, Nigel Hunton, Michele F. Klein, Eiji Miyanaga, and Ryan Vardeman resigned from his or her respective positions as a member of the Company’s board of directors and all committees thereof, effective as of the Effective Time
Departed
Nigel Hunton
Director
INTEVAC INC
Effective
2025-03-31
Filed
March 31, 2025, 7:59 PM ET
each of Kevin Barber, David S. Dury, Dorothy D. Hayes, Nigel Hunton, Michele F. Klein, Eiji Miyanaga, and Ryan Vardeman resigned from his or her respective positions as a member of the Company’s board of directors and all committees thereof, effective as of the Effective Time
On March 28, 2025, Lynn L. Elsenhans informed Baker Hughes Company (the “Company”) that she will not stand for re-election at the Company’s upcoming 2025 Annual Meeting of Shareholders (the “2025 Annual Meeting”).
Effective March 25, 2025, the Board of Directors (the “Board”) of FTI Consulting, Inc. (“FTI Consulting” or the “Company”) elected Eric Steigerwalt and Janet Zelenka as independent directors of FTI Consulting.
Effective March 25, 2025, the Board of Directors (the “Board”) of FTI Consulting, Inc. (“FTI Consulting” or the “Company”) elected Eric Steigerwalt and Janet Zelenka as independent directors of FTI Consulting.
On March 28, 2025, the Board of Directors (the “Board”) of Codexis, Inc. (the “Company”), upon the recommendation of the Board’s Nominating and Corporate Governance Committee, appointed Cynthia Collins as a member of the Board as a Class II director, effective immediately.
the Board appointed Kathleen Valiasek, who currently serves as the Company’s Chief Financial Officer and President, as Chief Executive Officer of the Company, effective March 31, 2025.
Craig M. Hurlbert announced his intention to resign as the Company’s Chief Executive Officer, effective March 31, 2025. The Board appointed Mr. Hurlbert as Executive Chairman on March 27, 2025, effective as of March 31, 2025.
Simultaneous with the closing of the Transaction, Justin Cochrane, Chief Executive Officer of Clear Channel UK & Europe, has ceased to be an employee of the Company.
the Company and Tarak B. Mehta, the President and Chief Executive Officer of the Company, had mutually agreed that Mr. Mehta would depart from the Company, including resigning as a member of the Company’s Board of Directors (the “Board”), effective immediately.
On March 25, 2025, it was agreed that the employment of Eric Hyllengren, the Chief Financial Officer and Chief Operating Officer of Atara Biotherapeutics, Inc. (the “ Company ”), would end effective March 31, 2025.
On March 31, 2025, the Company appointed Yanina Grant-Huerta as the Company’s Chief Accounting Officer and principal accounting officer, effective March 31, 2025.
On March 31, 2025 (the “ Transition Date ”), Universal Technical Institute, Inc., a Delaware corporation (the “ Company ”), announced the transition of Todd Hitchcock to the role of Chief Operating Officer, effective immediately (the “ Transition ”).
Appointed
Steve Forte
President and Chief Executive Officer
Repare Therapeutics Inc.
Effective
2025-04-11
Filed
March 31, 2025, 7:59 PM ET
the Board appointed Steve Forte to serve as the Company’s President and Chief Executive Officer in addition to his current role as the Company’s Chief Financial Officer, effective as of the Effective Date.
Departed
Lloyd Segal
President and Chief Executive Officer
Repare Therapeutics Inc.
Effective
2025-04-11
Successor
Steve Forte
Filed
March 31, 2025, 7:59 PM ET
On March 31, 2025, Lloyd Segal, President and Chief Executive Officer of Repare Therapeutics Inc. (the “ Company ”), notified the board of directors (the “ Board ”) of the Company of his resignation from his positions as President and Chief Executive Officer and as a member of the Board, effective April 11, 2025
On March 27, 2025, the Board terminated Michael T. Broderick from his positions as President and Chief Executive Officer of the Company effective immediately.
On March 28, 2025, the Board of Directors (“Board”) of Monro, Inc. (the “Company”) appointed Peter Fitzsimmons to serve as the President and Chief Executive Officer of the Company effective immediately.
On March 27, 2025, the Board of Directors appointed Jaime Fickett, the Company’s current Interim Chief Financial Officer, to the position of Chief Financial Officer, effective immediately.
James L. Marvin, the Executive Vice President and Chief Legal Officer of JBT Marel Corporation (the “Company”), announced his intention to retire on May 31, 2025.
Justin G. Cox, age 44, currently serving as an Executive Vice President and Regional President of the Company and the Bank, is being promoted to the position of Executive Vice President and Chief Banking Officer of the Company and the Bank.
Appointed
G. David Jackola
Executive Vice President and Chief Financial Officer
On and effective as of March 28, 2025, the Board of Directors of the Company approved the appointment of Mr. Jackola as the Company’s Executive Vice President and Chief Financial Officer.
On March 25, 2025, Jeetu Patel, a member of the Board of Directors (the “Board”) of Equinix, Inc. (the “Company”) since June 2022, notified the Board that he would not stand for reelection as a director of the Company.
the Company's Chief Financial Officer, Sunit Patel, resigned, and Valarie Sheppard, a member of the Company's Board of Directors (the 'Board'), assumed the role of Interim Chief Financial Officer, effective March 14, 2025.
the Company's Chief Financial Officer, Sunit Patel, resigned, and Valarie Sheppard, a member of the Company's Board of Directors (the 'Board'), assumed the role of Interim Chief Financial Officer, effective March 14, 2025.
On March 31, 2025, Ardent Health Partners, Inc. (the “Company”) announced that David Caspers, 54, has been appointed as the Company’s Chief Operating Officer, effective March 31, 2025.
On February 25, 2025, Mr. Ernest Scheidemann informed First Choice Healthcare Solutions, Inc. (the “Company”) of his resignation as the Interim Chief Financial Officer of the Company, effective as of February 25, 2025.
Joseph Hummel resigned as Chief Executive Officer of Twin Hospitality Group Inc.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.